0001507673-22-000015.txt : 20220810 0001507673-22-000015.hdr.sgml : 20220810 20220810151256 ACCESSION NUMBER: 0001507673-22-000015 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220810 DATE AS OF CHANGE: 20220810 EFFECTIVENESS DATE: 20220810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RP Management, LLC CENTRAL INDEX KEY: 0001507673 IRS NUMBER: 611450238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19261 FILM NUMBER: 221151567 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET STREET 2: SUITE 3300 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET STREET 2: SUITE 3300 CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001507673 XXXXXXXX 06-30-2022 06-30-2022 RP Management, LLC
110 East 59th Street Suite 3300 NEW YORK NY 10022
13F HOLDINGS REPORT 028-19261 N
Jason Mehar VP, Investments & Deputy General Counsel 212-883-0200 /s/ Jason Mehar New York NY 08-10-2022 1 5 253203 false 1 0001507678 028-19630 Legorreta Pablo G.
INFORMATION TABLE 2 information_table.xml INFORMATION TABLE BIOHAVEN PHARMACTL HLDG CO L COM G11196105 161900 1111111 SH DFND 1 1111111 0 0 VIRACTA THERAPEUTICS INC COM 92765F108 18 3700 SH DFND 1 3700 0 0 EPIZYME INC COM 29428V104 46807 31841394 SH DFND 1 31841394 0 0 EPIZYME INC COM 29428V904 3786 2575450 SH Call DFND 1 2575450 0 0 BIOCRYST PHARMACEUTICALS INC COM 09058V103 40692 3846154 SH DFND 1 3846154 0 0